3Eaton CL,Wells JM,Holen I,et al.Serum osteoprotegerin (OPG)levels are associated with disease progression and response to androgen ablation in patients with prostate cancer[J].Prostate,2004,59(3):304-310.
4Brown JM,Vessella RL,Kostenuik PJ,et al.Serum ostceprotegerin levels are increased in patients with advanced prostate cancer[J].Clin Cancer Res,2001,7(10):2977-2983.
5Jung K,Stephan C,Semjonow A,et al.Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer[J].J Urol,2003,170(6 Pt 1):2302-2305.
6Perkel VS,Mohan S,Herring SJ,et al.Human prostatic cancer cells,PC3,elaborate mitogenic activity which selectively stimulates human bone cells[J].Cancer Res,1990,50(21):6902-6907.
7Ulsperger E,Hamilton G,Raderer M,et al.Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supematants[J].Int J Oncol,1999,15(5):955-959.
8Brown JM,Vessella RL,Kostenuik PJ,et al.Serum osteoprotegerin levels are increased in patients with advanced prostate cancer[J].Clin Cancer Res,2001,7(10):2977-2983.
9Milos J. Janicek M.D., Ph.D.,Kitt Shaffer M.D., Ph.D.. Scintigraphic and radiographic patterns of skeletal metastases in breast cancer: value of sequential imaging in predicting outcome[J] 1995,Skeletal Radiology(8):597～600
10Soloway MS,Hardeman SW,Hickey D,et al.Stratification of patients with metastatic cancer based on extent of disease on initial bone scan[].Cancer.1988
